Generic initiatives planned for 2012
As part of our commitment to keep health care affordable, we’ll be encouraging members taking certain brand-name cholesterol–lowering drugs to discuss generic alternatives with their PCP. Letters will be mailed to members taking brand-name statins, informing them of the newly available generic atorvastatin. We’ll also mail letters to members taking Trilipix advising them of available generic fenofibrate options. There are three reasons for this initiative:
- Generics within these classes may be clinically safe and effective alternatives to brand–name products.
- Patients save money. We will waive the first copayment for commercial members who switch to a generic. Members continue to save money through sustained low-cost generic copayments.
- It positively impacts your 2012 incentive program measures by increasing the percentage of your generic prescriptions.
| Drug Class | If you prescribe: | Consider this instead: |
|---|
| Statins |
Advicor
Altoprev
Crestor
Lescol/XL
Livalo
Simcor
Vytorin |
atorvastatin (generic Lipitor)
simvastatin (generic Zocor)
pravastatin (generic Pravachol)
lovastatin (generic Mevacor) |
| Fibric acid derivatives |
Trilipix |
gemfibrozil (generic Lopid)
fenofibrate (generic Lofibra)
fenofibrate, micronized (generic Antara) |
If you would like a copy of the member letter and/or a list of your patients taking these brand–name medications, please
contact your PAR.
Topics: Priority Health updates
